WHITEHAWK THERAPEUTICS, INC. Net Income (Loss) Available to Common Stockholders, Diluted
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$60.51 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2023-03-29
- WHITEHAWK THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2021-12-31 was -$15.99M.
- WHITEHAWK THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2021-09-30 was -$87.24M.
- WHITEHAWK THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$60.51M.
- WHITEHAWK THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for fiscal 2021 was -$110.74M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$60.51M 10-K · filed 2023-03-29 | |||
| 2021-12-31 | -$15.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$103.23M derived: sum of 2 quarters · filed 2023-03-29 | -$110.74M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$87.24M 10-Q · filed 2022-11-09 | -$94.75M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |